RESULTATS SEMESTRIELS 2024
September 05, 2024 01:30 ET
|
Voltalia
RESULTATS SEMESTRIELS 2024 EBITDA en croissance de +34% à 75 millions d’euros Confirmation des objectifs de capacité à fin d’année 2024 Résultats semestriels 2024 Chiffre d’affaires : +28% à 248,9...
2024 HALF-YEAR RESULTS
September 05, 2024 01:30 ET
|
Voltalia
2024 HALF-YEAR RESULTS EBITDA up +34% to 75 million euros Confirmation of 2024 year-end capacity targets Half-year results 2024 Turnover: +28% to 248.9 million euros, driven by +26% growth...
BGHL (GBP): NAV(s)
September 05, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
BGHL (EUR): NAV(s)
September 05, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Monthly information on share capital and company voting rights
September 04, 2024 16:30 ET
|
Cellectis Inc.
PARIS, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
September 04, 2024 16:30 ET
|
Cellectis Inc.
PARIS, 04 sept. 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 DateNombre total d’actions composant le capital socialNombre total de droits de...
DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment
September 04, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, 4 septembre, 2024 (22:30 CET) DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment DBV Technologies (Euronext : DBV - ISIN : FR0010417345 -...
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, September 4, 2024 DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq...
NANOBIOTIX annonce deux ajouts clés auprès de son conseil de surveillance dans la perspective d’une croissance durable et à long terme de la société
September 04, 2024 16:15 ET
|
Nanobiotix S.A.
Dr Margaret A. Liu, experte mondiale en vaccins, thérapie génique et immunothérapie contre le cancer, Chief Executive Officer chez PAX Therapeutics et membre de plusieurs conseils d’administrationAnat...
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
September 04, 2024 16:15 ET
|
Nanobiotix S.A.
Dr. Margaret A. Liu, global expert in vaccines, gene therapy, and cancer immunotherapy; chief executive officer of PAX Therapeutics and member of several boardsMs. Anat Naschitz, proven life science...